Byung-Hwa Hyun

This inventor holds 9 USPTO granted patents. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Korea Institute of Science and Technology. Active years: 2000-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung-Hwa Hyun. Retrieved from https://idiyas.com/inventor/byung-hwa-hyun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9

% Patents Active = 77.8

Average Co-Inventor Count = 12.9

ph-index = 5

Forward Citations = 404(Granted Patents)

Company Filing History:

5 out of 335

Korea Research Institute of Bioscience and Biotechnology

patents

4 out of 2,251

Korea Institute of Science and Technology

patents

Years Active: 2000-2003

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6562866 - Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin (2003-05-13),

2. 6509372 - Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin (2003-01-21),

3. 6465019 - Health-improving spice composition (2002-10-15),

4. 6455577 - Flavanone derivatives and composition for preventing or treating blood lipid level-related diseases comprising same (2002-09-24),

5. 6313171 - Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives (2001-11-06),

6. 6165984 - Naringin and naringenin as inhibitors of acyl (2000-12-26),

7. 6133311 - Method for preventing or treating elevated blood lipid level-related (2000-10-17),

8. 6133241 - Bioflavonoids as plasma high density lipoprotein level increasing agent (2000-10-17),

9. 6096364 - Method for lowering blood glucose level by the administration of (2000-08-01),

Title: Byung-Hwa Hyun: Innovator in Health Solutions

Introduction

Byung-Hwa Hyun is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of health and biotechnology, holding a total of nine patents. His work primarily focuses on methods for preventing and treating diseases related to elevated blood lipid levels.

Latest Patents

Among his latest patents is a method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin. This innovative approach involves administering an effective amount of these compounds to mammals, aiming to improve health outcomes related to lipid levels. The method emphasizes the potential of rutin and quercetin as effective agents in managing blood lipid levels.

Career Highlights

Throughout his career, Byung-Hwa Hyun has worked with esteemed institutions such as the Korea Research Institute of Bioscience and Biotechnology and the Korea Institute of Science and Technology. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in health-related technologies.

Collaborations

Byung-Hwa Hyun has collaborated with notable colleagues, including Song-Hae Bok and Tae-Sook Jeong. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.

Conclusion

Byung-Hwa Hyun's contributions to health solutions through his patents and collaborations highlight his role as an influential inventor in the biotechnology sector. His work continues to pave the way for advancements in the treatment of elevated blood lipid levels.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]